Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | AMGN | VRTX | REGN | BMY |
| Company | Csl Ltd ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 90.7500 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 90.7500 | 276.41 | 396.12 | 897.59 | 44.47 |
| Low | 88.7300 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 89.5150 | 276.45 | 396.34 | 898.75 | 44.31 |
| Change | -0.0850 | +2.51 | +3.53 | +8.09 | +0.37 |
| % Change | -0.09% | +0.92% | +0.90% | +0.91% | +0.84% |
| Volume | 30,174 | 337,223 | 132,560 | 62,286 | 3,688,476 |
| 20-Day Average Volume | 43,084 | 2,140,929 | 942,813 | 449,388 | 13,576,462 |
| Previous Close | 89.6000 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 90.2206 | 269.58 | 398.54 | 908.58 | 48.21 |
| 20-Day Raw Stochastic | 42.47% | 90.51% | 17.94% | 19.90% | 3.67% |
| 20-Day Relative Strength | 44.66% | 50.94% | 41.40% | 37.86% | 27.62% |
| Weighted Alpha | -9.20 | +13.40 | +11.92 | +15.21 | -36.58 |
| Today's Opinion | 8% Sell | 24% Sell | 24% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 8% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 56% Buy | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.65% since 04/24/24 | +0.85% since 04/24/24 | -1.46% since 04/24/24 | -1.55% since 04/24/24 | -9.88% since 04/24/24 |
| Low | 88.7300 on 05/01/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 91.7500 on 04/29/24 | 276.86 on 04/29/24 | 403.88 on 04/25/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -4.26% since 04/01/24 | -2.73% since 04/01/24 | -6.09% since 04/01/24 | -7.92% since 04/01/24 | -16.90% since 04/01/24 |
| Low | 85.9600 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 94.3900 on 04/02/24 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | -8.38% since 02/01/24 | -15.17% since 02/01/24 | -8.98% since 02/01/24 | -6.81% since 02/01/24 | -9.52% since 02/01/24 |
| Low | 85.9600 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 99.4900 on 02/09/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +19.43% since 11/01/23 | +5.55% since 11/01/23 | +6.92% since 11/01/23 | +12.80% since 11/01/23 | -14.13% since 11/01/23 |
| Low | 75.2000 on 11/02/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 99.9500 on 12/27/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 86,598,848 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 966,505 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 13,310,000,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | 2,194,000,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.73 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 09/27/23 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | 0.545 on 03/11/24 | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | 03/11/24 | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |